Metanovas Biotech

Metanovas is a provider of an AI-enabled drug and disease discovery platform
2021
30
Shanghai, China

Innovation

Industry Problem

Traditional method of drug discovery is time consuming

R&D Focus

AI-enabled drug and disease discovery platform

Innovative Solution

Metanovas provides a drug and disease discovery platform empowered by machine learning and AI to discover novel disease targets, screen for potential drugs, repurpose existing drugs for new indication

Solution Effectiveness

Metanovas Ai enabled drug discovery platform results in 45% more success in R&D

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

$1.57M

Last Funding Amount

$1.57M

Startup Stage

Early Stage

Lead Investors

Redhill Capital, Sinopharm Capital

People

Founders

CEO

Products

Product

MetaAMP5, MetaAMP33, MetaCono, MetaPep-Ocean-1, MetaAMP12

Demo Product or Complete Product?

Complete Product

Awards and Recognitions

Awards

Best AI-Led Functional Food Development Firm of 2023 by LUXlife Magazine

Media Apperance

Business Insider, Bloomberg, Yahoo Finance

M&A and Collabs

Collab

Loreal

Collab

Gsk